findmyKOL
Clinical trialNCT00482677CompletedPhase 3Interventional

Radiation Therapy With or Without Temozolomide in Treating Older Patients With Newly Diagnosed Glioblastoma Multiforme

SponsorCanadian Cancer Trials GroupEnrollment562Brain and Central Nervous System Tumors
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Tom Baker Cancer Centre

    Calgary, Alberta, Canada

  • Cross Cancer Institute

    Edmonton, Alberta, Canada

  • Bcca - Fraser Valley Cancer Centre

    Surrey, British Columbia, Canada

  • Bcca - Vancouver Cancer Centre

    Vancouver, British Columbia, Canada

  • Bcca - Vancouver Island Cancer Centre

    Victoria, British Columbia, Canada

  • Cancercare Manitoba

    Winnipeg, Manitoba, Canada

  • Atlantic Health Sciences Corporation

    Saint John, New Brunswick, Canada

  • Qeii Health Sciences Centre

    Halifax, Nova Scotia, Canada

  • Juravinski Cancer Centre at Hamilton Health Sciences

    Hamilton, Ontario, Canada

  • London Regional Cancer Program

    London, Ontario, Canada

  • Odette Cancer Centre

    Toronto, Ontario, Canada

  • Univ. Health Network-Princess Margaret Hospital

    Toronto, Ontario, Canada

  • Chum - Hopital Notre-Dame

    Montreal, Quebec, Canada

  • Mcgill University - Dept. Oncology

    Montreal, Quebec, Canada

  • Centre Hospitalier Universitaire de Sherbrooke

    Sherbrooke, Quebec, Canada

  • Centre Hospitalier Regional de Trois-Rivieres

    Trois-Rivières, Quebec, Canada

Germany
  • Klinikum Der J.W. Goethe Universitaet

    Frankfurt, Germany

  • Universitaetsklinikum Freiburg

    Freiburg im Breisgau, Germany

  • Universitaetsklinikum Leipzig

    Leipzig, Germany

  • Universitaetsklinikum Tuebingen

    Tübingen, Germany

Japan
  • Hiroshima University Hospital

    Hiroshima, Japan

Netherlands
  • Maastro - Maastricht Radiation Oncology

    Maastricht, Netherlands

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
14 Nov 2007
Primary completion
1 Mar 2016
Completion
10 Aug 2016
Last update posted
22 Aug 2023
Registered enrollment
562
Registry id
NCT00482677
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.